Hemiparetic cerebral palsy: clinical pattern and imaging in prediction of outcome.

BACKGROUND

Hemiparetic cerebral palsy (HCP) is described as having two main forms: arm-dominant, associated with large cortical/subcortical lesions; leg-dominant, associated with lesions of central white matter. Epilepsy and cognitive deficits are common in the former pattern and rare in the latter. Some authors have recommended routine imaging studies in children with HCP as an assessment of etiology and a predictor of outcome. The present study compares the relative values of clinical analysis and imaging in predicting epilepsy and cognitive disabilities.

METHODS

Forty-one consecutive patients with HCP underwent careful clinical assessment and imaging studies (primarily computed tomography) and were followed prospectively for the development of recurrent afebrile seizures and academic difficulties.

RESULTS

Twenty of the 41 patients (48.8%) were arm-dominant, 14/41 (34.1%) leg-dominant, and 7/41 (17.1%) proportional (arm = leg). The principal imaging findings were: arm-dominant patients - large arterial infarcts, porencephalic cysts, brain malformations; leg-dominant - periventricular leukomalacia; proportional - porencephaly. Arm-dominant hemiparesis and radiologic evidence of cortical pathology were both predictive of cognitive deficits (odds ratios 14.2 [95% CI 2.6, 75.8] and 5.7 [95% CI 1.4. 22.3] respectively). For the development of epilepsy, both evaluation techniques were again predictive, with imaging findings of cortical pathology being particularly powerful (clinical pattern OR 18.0 [95% CI 3.0, 107.7]; imaging OR 80.7 [95% CI 8.5, 767.3]).

CONCLUSIONS

In this study, the clinical pattern of HCP and the radiological findings were both predictive of outcome, with absence of cortical pathology on imaging being particularly predictive for the absence of epilepsy. While the clinical pattern, in isolation, appears helpful in predicting outcome, our results suggest that both evaluation tools have important roles to play in the evaluation of HCP patients.